Alnylam Pharmaceuticals competitorsClear all

Alnylam Pharmaceuticals's top competitors include CureVac, Regulus Therapeutics, Reata Pharmaceuticals, Moderna, Ionis Pharmaceuticals, Sorrento Therapeutics, Celyad and Sarepta Therapeutics.

Save Comparison	Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.	CureVac CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.	Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.	Moderna Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.	Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.	Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Founding Date	Founding Date 2002	Founding Date 2000	Founding Date 2007	Founding Date 2002	Founding Date N/A	Founding Date 1989	Founding Date 2006	Founding Date 2007	Founding Date 1980
Type	Type Public	Type Private	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Cambridge, US HQ Paris, FR Milano, IT Amsterdam, NL Stockholm, SE Zug, CH Maidenhead, GB	Locations Tübingen, DE HQ Frankfurt Am Main, DE Tübingen, DE Boston, US	Locations San Diego, US HQ	Locations Plano, US HQ Irving, US Plano, US	Locations Cambridge, US HQ Huddinge, SE Cambridge, US Norwood, US	Locations Carlsbad, US HQ	Locations San Diego, US HQ San Diego, US	Locations Mont-Saint-Guibert, BE HQ New York, US	Locations Cambridge, US HQ Boulogne Billancourt, FR Berlin, DE Dublin, IE Milano, IT Chiyoda City, JP see more
Employees	Employees 1,32324% increase	Employees 4004% increase	Employees 2462% decrease	Employees 22079% increase	Employees 8309% increase	Employees 7577% decrease	Employees 31019% decrease	Employees 87	Employees 74349% increase
Valuation ($)	Valuation ($) 17.7 b	Valuation ($) 1.5 b	Valuation ($) 22.5 m	Valuation ($) 830.2 m	Valuation ($) 85.2 b	Valuation ($) 4.5 b	Valuation ($) 1.3 b	Valuation ($) 63.3 m	Valuation ($) 6.3 b
Twitter followers	Twitter followers 14.8 k	Twitter followers 7	Twitter followers 813	Twitter followers 1.3 k	Twitter followers 140.8 k	Twitter followers 3.8 k	Twitter followers N/A	Twitter followers 2.4 k	Twitter followers 3.9 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 25	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 9	Number of tweets (last 30 days) 44	Number of tweets (last 30 days) 4	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 9	Number of tweets (last 30 days) 8
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 19.2	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 2.1	Average likes per tweet (last 30 days) 136.8	Average likes per tweet (last 30 days) 7.3	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 3	Average likes per tweet (last 30 days) 15.1
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 88.89%	Percentage of tweets with engagement (last 30 days) 100%
Alexa Website Rank	Alexa Website Rank 302137	Alexa Website Rank 210991	Alexa Website Rank 492239	Alexa Website Rank 569068	Alexa Website Rank 134685	Alexa Website Rank 358001	Alexa Website Rank 210216	Alexa Website Rank N/A	Alexa Website Rank 181719
Employee Rating	Employee Rating 4.3	Employee Rating 3.5	Employee Rating 2.7	Employee Rating 3.9	Employee Rating 3.9	Employee Rating 3.8	Employee Rating 3.3	Employee Rating 3.5	Employee Rating 3.6
Financial
Revenue (est.)	Revenue (est.) $492.9m (FY, 2020)	Revenue (est.) €12.6m (FY, 2018)	Revenue (est.) $10m (FY, 2020)	Revenue (est.) $9m (FY, 2020)	Revenue (est.) $803.4m (FY, 2020)	Revenue (est.) $729.3m (FY, 2020)	Revenue (est.) $40m (FY, 2020)	Revenue (est.) €3.5m (FY, 2017)	Revenue (est.) $540.1m (FY, 2020)
Cost of goods	Cost of goods $78.1m (FY, 2020)	Cost of goods €22.3m (FY, 2018)	Cost of goods N/A	Cost of goods N/A	Cost of goods $7.9m (FY, 2020)	Cost of goods $11.9m (FY, 2020)	Cost of goods N/A	Cost of goods €515k (FY, 2017)	Cost of goods N/A
Gross profit	Gross profit $414.8m (FY, 2020)	Gross profit (€9.8m) (FY, 2018)	Gross profit N/A	Gross profit N/A	Gross profit $795.5m (FY, 2020)	Gross profit $717.3m (FY, 2020)	Gross profit N/A	Gross profit €3m (FY, 2017)	Gross profit N/A
Net income	Net income ($858.3m) (FY, 2020)	Net income (€74.6m) (FY, 2018)	Net income ($15.7m) (FY, 2020)	Net income ($247.8m) (FY, 2020)	Net income ($747.1m) (FY, 2020)	Net income ($486.8m) (FY, 2020)	Net income ($314.4m) (FY, 2020)	Net income (€56.4m) (FY, 2017)	Net income ($554.1m) (FY, 2020)
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications 500 (Mar, 2020)	Patent Applications N/A	Patent Applications N/A	Patent Applications 250 (May, 2017)	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A
Patents Issued	Patents Issued N/A	Patents Issued 233 (May, 2020)	Patents Issued 300 (FY, 2016)	Patents Issued 240 (FY, 2016)	Patents Issued 100 (Q3, 2018)	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A
Phase I Trials Products	Phase I Trials Products N/A	Phase I Trials Products 3 (May, 2020)	Phase I Trials Products N/A	Phase I Trials Products 2 (FY, 2016)	Phase I Trials Products N/A	Phase I Trials Products 6 (FY, 2020)	Phase I Trials Products N/A	Phase I Trials Products N/A	Phase I Trials Products N/A
Phase II Trials Products	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products 4 (FY, 2016)	Phase II Trials Products N/A	Phase II Trials Products 24 (FY, 2020)	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products N/A
Phase III Trials Products	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products 1 (FY, 2016)	Phase III Trials Products N/A	Phase III Trials Products 6 (FY, 2020)	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A
Funding
Total funding raised	Total funding raised $ 1.5b	Total funding raised $ 1.1b	Total funding raised $ 10m	Total funding raised $ 468.9m	Total funding raised $ 1.8b	Total funding raised N/A	Total funding raised $ 42.6m	Total funding raised N/A	Total funding raised N/A